At the core of personalized nanomedicines are nanocarriers, which can be engineered to encapsulate therapeutic agents. These nanocarriers can be functionalized with specific ligands or antibodies that recognize and bind to particular cell markers. Upon reaching the target site, the nanocarriers release their payload in a controlled manner, ensuring that the therapeutic agent acts precisely where needed.
